[在局部性NSCLC中取代辅助向疗法]
1Institut du Thorax Curie Montsouris, Institut Curie, Paris et Saint-Cloud; UFR Simone Veil, UVSQ, Université Paris Saclay, Versailles, France.
Bulletin du cancer
|March 28, 2025
概括
辅助类氨酸激酶抑制剂在手术后对EGFR突变和ALK阳性肺癌患者有益. 建议在手术样本和活检中检测这些突变,尽管治疗细节需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胸部外科手术 胸部外科手术
背景情况:
- 患有EGFR突变或ALK重组的非小细胞肺癌 (NSCLC) 患者从向治疗中受益.
- 用氨酸激酶抑制剂 (TKIs) 辅助治疗在特定NSCLC亚型的手术切除后显示出有前途.
- 目前的指导方针建议对这些驾驶员改变进行测试.
研究的目的:
- 要突出助剂TKI在EGFR突变和ALK阳性NSCLC中的好处.
- 强调手术样本和活检上的分子检测的重要性.
- 确定关于技术智能实施的未来研究的重点领域.
主要方法:
- 审查当前的临床证据和指导方针.
- 分析分子测试在NSCLC管理中的作用.
- 确定未解决的临床问题.
主要成果:
- 在EGFR突变和ALK阳性NSCLC患者受益于完整切除后的辅助TKI治疗.
- 对EGFR突变和ALK阳性的测试对于指导辅助治疗决策至关重要.
- 关键的实施问题包括最佳的治疗持续时间,复发的管理,以及对分子进化的影响.
结论:
- 辅助性TKI代表了特定NSCLC患者群体的有价值策略.
- 标准化分子检测对于识别符合条件的患者至关重要.
- 需要进一步的研究,以解决治疗持续时间,复发管理和辅助TKI治疗的背景下分子演变.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


